Royalty Pharma PLC (RPRX) Price Prediction & ForecastRPRXRoyalty Pharma PLC

Alphio's RPRX stock price prediction model matches the current Royalty Pharma PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $61.45 (+0.81%). The 1-week path is $61.05 (+0.15%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Royalty Pharma PLC is a good buy right now due to its strong financial performance and positive market sentiment. The current price is $56.93, with a forward P/E ratio of 29.41, suggesting growth potential. Additionally, the stock has appreciated 46.50% year-to-date, indicating strong investor confidence. However, the RSI is at 43.04, which suggests that the stock is nearing oversold territory, presenting a buying opportunity. The main risk is the recent decline in net income, which dropped to $17.88 million in Q2 2026, compared to $294.69 million in Q1 2026, highlighting volatility in earnings.

Royalty Pharma PLC (RPRX) last closed at $60.96, gaining +2.25%. These facts feed the 1-day and 1-week RPRX price prediction above.